Podcasts about Grand rounds

This is a capstone presentation from Chief Resident of Mayo Clinic Emergency Medicine, Dr. Taylor Christian.   Teaser: Can we fulfill our oath to “do no harm” if we ignore the harm of racial injustice in medicine? Understanding the historical roots and persistent impact of medical racism isn't just informative; it is a call to action. This presentation is an opportunity to learn, reflect, and act to become better advocates.   CONTACTS X - @AlwaysOnEM; @VenkBellamkonda; @TayMChristian YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch; @drtaylormonet Email - AlwaysOnEM@gmail.com   REFERENCES & LINKS Meisel ZF, Shofer FS, Dolan AR, Goldberg E, Cannuscio CC, Rhodes KV, Perrone J, Hess EP, Rogers M, Bellamkonda V, Bell J, Zyla M, Becker L, McCollum S, Schapira M. Comparing Three Ways to Help Patients with Acute Pain Learn about Opioid Risks — The Life STORRIED Study [Internet]. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Oct. PMID: 39383261. Engel-Rebitzer E, Dolan AR, Aronowitz SV, Shofer FS, Nguemeni Tiako MJ, Schapira MM, Perrone J, Hess EP, Rhodes KV, Bellamkonda VR, Cannuscio CC, Goldberg E, Bell J, Rodgers MA, Zyla M, Becker LB, McCollum S, Meisel ZF. Patient Preference and Risk Assessment in Opioid Prescribing Disparities: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2021 Jul 1;4(7):e2118801. doi: 10.1001/jamanetworkopen.2021.18801. PMID: 34323984; PMCID: PMC8322998. Racic M, Roche-Miranda MI, Fatahi G. Twelve tips for implementing and teaching anti-racism curriculum in medical education. Med Teach. 2023 Aug;45(8):816-821. doi: 10.1080/0142159X.2023.2206534. Epub 2023 May 3. PMID: 37134226. Sahai A, Corley AMS, Lipps L, Lawton R, DeBlasio D, Klein M. A Locally-Focused Structural Racism Curriculum for Pediatric Primary Care Residents. Acad Pediatr. 2023 Nov-Dec;23(8):1510-1512. doi: 10.1016/j.acap.2023.06.012. Epub 2023 Jun 9. PMID: 37302703. Carrera D, Tejeda C, Kakani P, Napolitano J. Addressing Racism in Medical Education: A Longitudinal Antiracism Discussion Curriculum for Medical Students. Med Sci Educ. 2023 Apr 28;33(3):639-643. doi: 10.1007/s40670-023-01788-x. PMID: 37501797; PMCID: PMC10368613. Seegmiller Renner AM, Gross JR, Laughlin-Tommaso SK. Paving a Path to Inclusion, Diversity, Anti-Racism, and Equity: A Curriculum Roadmap. Mayo Clin Proc. 2023 Dec;98(12):1755-1762. doi: 10.1016/j.mayocp.2023.08.026. PMID: 38043992.

With federal funding at risk and VCs increasingly focused on de-risked assets, academia is facing unprecedented headwinds despite rapid advancements in innovation. One potential bright spot: Pharma, which is turning to academia to access first-in-class innovation. But many in pharma complain it is difficult to work with academia.On a special Grand Rounds edition of the BioCentury This Week podcast, BioCentury analysts and special guests discuss a new way of thinking and a new era of collaboration between academia and industry.View full story: https://www.biocentury.com/article/656177#biotech #biopharma #pharma #lifescience #Discovery #Translation #BioCenturyGrandRounds00:00 - Introduction02:38 - Key Findings07:42 - Collaboration and Opportunities 25:52 - BioCentury Grand Rounds EuropeTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Here's the link for CME credit! https://cmetracker.net/UTHSCSA/Publisher?page=pubOpen#/getCertificate/10098810 Host Holly Wayment brings us a grand rounds episode with Radhika B. Pillai, MD as she delves into the importance of bone health in children. With a strong foundation in cystic fibrosis research, Dr. Pillai explores critical pediatric concerns such as calcium growth, puberty disorders, diabetes, and obesity. In this episode, Dr. Pillai emphasizes the significance of bone health, highlighting its often-under appreciated role in pediatric care. She provides insights into the assessment and diagnosis of bone disorders, focusing on gathering comprehensive medical histories, conducting thorough examinations, and exploring the impacts of nutritional deficiencies. Through an engaging clinical case study, Dr. Pillai discusses diagnostic techniques, imaging methods, and laboratory tests vital for identifying conditions like vitamin D deficiency rickets. Her expertise illuminates the complex interplay of calcium and phosphate homeostasis, offering valuable perspectives on effective treatment strategies and the importance of early identification.

Event Objectives:Learn about two measures of weight stigma: weight bias internalization and weight-based teasing.Understand the characteristics associated with higher weight bias internalization in adolescents with Type 1 diabetes mellitus.Share findings of three PDSA cycles initiated to improve utilization metrics of medication historians in the inpatient setting.Discuss future goals to help improve metrics further.Identify cost drivers and potential areas for optimizing ADHD pharmacologic treatment under Medicaid with a focus on high-expenditure medications.Explore conditions that promote growth and toxin production by the Klebsiella oxytoca species complex.Review experimental model to explore link between endogenous glycan availability to Klebsiella toxin production and intestinal injury.Claim CME Credit Here!

Event Objectives:Increase knowledge and awareness of Outpatient Spinal Disorders.Identify when to refer spine patients.Discuss what is new in outpatient care of spine disorders.Claim CME Credit Here!

Dr. Molly Fuentes is medical director at the inpatient rehabilitation unit at the Seattle Children's Hospital. Dr. Fuentes is an assistant professor of rehabilitation medicine at the University of Medicine. She also is a pediatric physiatrist. She completed her undergraduate degree at Stanford University and is a graduate of the School of Medicine at the University of Michigan. She completed her residency at the University of Washington and later completed a pediatric fellowship at the Seattle Children's Hospital. She then completed a research fellowship in pediatric injury at the Harborview Injury Prevention and Research Center at the University of Washington. She is the medical director at the inpatient rehabilitation unit at the Seattle Children's Hospital.   Part 2 She indicated that the Indian Health Service per capita receives half of what Medicaid receives. Treaty-bound trusts for providing health care are chronically underfunded. The Indian Health Service operates under a funding cap, which is annually appropriated. In contrast, Medicare and Medicaid are entitlement programs. She then returned to looking back at the injury-equity framework. She wanted to dive into the pre-event phase factors for native children and teens. An example pertains to motor vehicle injuries. Tribal sovereignty means that tribal laws are what is important to safety on reservations roads, e.g., speed limits and seat belt use. She described various programs that aim to improve safety on tribal roads. She then discussed the post-event phase involving rehabilitation and the golden hour that affects health outcomes. Where native people mostly reside in the U.S., there are fewer trauma centers. A related topic is models of access to health care services. The acceptability of these services by patients is a key element in the quality of health care provided.  High rates of health uninsurance affect this population negatively.

The turbulence that has come with the Trump administration's policies related to the U.S. biopharmaceutical industry is creating an opening for Europe to bolster its life sciences industry. On the latest BioCentury This Week podcast, BioCentury's editors look at how Europe can capitalize on staffing cuts at FDA and NIH and an uncertain policy environment to lure back talent to bolster regulatory agencies and biotech R&D engines and attract assets and partners from China.The editors also discuss two biotech deals driven by former leaders of BD at Roche, Biomarin's James Sabry and Sophie Kornowski at Boston Pharmaceuticals. Under the leadership of Sabry and CEO Alexander Hardy, Biomarin delivered its first takeout in a decade by acquiring Inozyme as it positions itself to take advantage of a regulatory and policy environment that they believe is favorable to their rare disease strategy. CEO Kornowski, meanwhile, executed on a plan to focus her company on a single liver disease asset that GSK acquired for $1.2 billion up front. Finally, BioCentury's editors discuss the management shake-up at obesity company Novo Nordisk, where Lars Fruergaard Jørgensen, the leader who spearheaded Novo Nordisk's transformation into a dominant player in obesity, is stepping down.Chan Zuckerberg Chicago Biohub is hosting an exclusive, invite-only reception on June 3 — the eve of BioCentury's Grand Rounds conference — gathering top voices in biotech innovation and investment to exchange bold ideas, spark new collaborations and channel the energy of Chicago's thriving innovation ecosystem. If you're interested in attending, please register here. This episode was sponsored by Jeito Capital.View full story: https://www.biocentury.com/article/655964#biotech #biopharma #pharma #lifescience #politics #policy #law00:01 - Sponsor Message: Jeito Capital05:05 - European Biotech's Moment?19:00 - Boston Pharma, Biomarin Deals29:41 - Novo Nordisk CEOTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Event Objectives:Understand the symptom based ROME IV Criteria for diagnosing pediatric irritable bowel syndrome (IBS).Recognize the current concepts in pathogenesis of IBS.Review the diagnostic approach and current treatment strategies for pediatric IBS.Claim CME Credit Here!

In this grand rounds, Dr. Daniel Fiterman Molinari challenges the status quo of cardiac arrest care with thought provoking takes on the literature. Take a listen to his Capstone presentation and find yourself pondering whether you agree or disagree, and whether you need to go revisit the literature yourself. You may find your own heart skips a beat in this great episode.

Listen to ASCO's JCO Oncology Practice, Art of Oncology Practice article, "An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last” by Dr. David Johnson, who is a clinical oncologist at University of Texas Southwestern Medical School. The article is followed by an interview with Johnson and host Dr. Mikkael Sekeres. Through humor and irony, Johnson critiques how overspecialization and poor presentation practices have eroded what was once internal medicine's premier educational forum. Transcript Narrator: An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last, by David H. Johnson, MD, MACP, FASCO   Over the past five decades, I have attended hundreds of medical conferences—some insightful and illuminating, others tedious and forgettable. Among these countless gatherings, Medical Grand Rounds (MGRs) has always held a special place. Originally conceived as a forum for discussing complex clinical cases, emerging research, and best practices in patient care, MGRs served as a unifying platform for clinicians across all specialties, along with medical students, residents, and other health care professionals. Expert speakers—whether esteemed faculty or distinguished guests—would discuss challenging cases, using them as a springboard to explore the latest advances in diagnosis and treatment. During my early years as a medical student, resident, and junior faculty member, Grand Rounds consistently attracted large, engaged audiences. However, as medicine became increasingly subspecialized, attendance began to wane. Lectures grew more technically intricate, often straying from broad clinical relevance. The patient-centered discussions that once brought together diverse medical professionals gradually gave way to hyperspecialized presentations. Subspecialists, once eager to share their insights with the wider medical community, increasingly withdrew to their own specialty-specific conferences, further fragmenting the exchange of knowledge across disciplines. As a former Chair of Internal Medicine and a veteran of numerous MGRs, I observed firsthand how these sessions shifted from dynamic educational exchanges to highly specialized, often impenetrable discussions. One of the most striking trends in recent years has been the decline in presentation quality at MGR—even among local and visiting world-renowned experts. While these speakers are often brilliant clinicians and investigators, they can also be remarkably poor lecturers, delivering some of the most uninspiring talks I have encountered. Their presentations are so consistently lackluster that one might suspect an underlying strategy at play—an unspoken method to ensure that they are never invited back. Having observed this pattern repeatedly, I am convinced that these speakers must be adhering to a set of unwritten rules to avoid future MGR presentations. To assist those unfamiliar with this apparent strategy, I have distilled the key principles that, when followed correctly, all but guarantee that a presenter will not be asked to give another MGR lecture—thus sparing them the burden of preparing one in the future. Drawing on my experience as an oncologist, I illustrate these principles using an oncology-based example although I suspect similar rules apply across other subspecialties. It will be up to my colleagues in cardiology, endocrinology, rheumatology, and beyond to identify and document their own versions—tasks for which I claim no expertise. What follows are the seven “Rules for Presenting a Bad Medical Oncology Medical Grand Rounds.” 1.  Microscopic Mayhem: Always begin with an excruciatingly detailed breakdown of the tumor's histology and molecular markers, emphasizing how these have evolved over the years (eg, PAP v prostate-specific antigen)—except, of course, when they have not (eg, estrogen receptor, progesterone receptor, etc). These nuances, while of limited relevance to general internists or most subspecialists (aside from oncologists), are guaranteed to induce eye-glazing boredom and quiet despair among your audience. 2. TNM Torture: Next, cover every nuance of the newest staging system … this is always a real crowd pleaser. For illustrative purposes, show a TNM chart in the smallest possible font. It is particularly helpful if you provide a lengthy review of previous versions of the staging system and painstakingly cover each and every change in the system. Importantly, this activity will allow you to disavow the relevance of all previous literature studies to which you will subsequently refer during the course of your presentation … to wit—“these data are based on the OLD staging system and therefore may not pertain …” This phrase is pure gold—use it often if you can. NB: You will know you have “captured” your audience if you observe audience members “shifting in their seats” … it occurs almost every time … but if you have failed to “move” the audience … by all means, continue reading … there is more! 3. Mechanism of Action Meltdown: Discuss in detail every drug ever used to treat the cancer under discussion; this works best if you also give a detailed description of each drug's mechanism of action (MOA). General internists and subspecialists just LOVE hearing a detailed discussion of the drug's MOA … especially if it is not at all relevant to the objectives of your talk. At this point, if you observe a wave of slack-jawed faces slowly slumping toward their desktops, you will know you are on your way to successfully crushing your audience's collective spirit. Keep going—you are almost there. 4. Dosage Deadlock: One must discuss “dose response” … there is absolutely nothing like a dose response presentation to a group of internists to induce cries of anguish. A wonderful example of how one might weave this into a lecture to generalists or a mixed audience of subspecialists is to discuss details that ONLY an oncologist would care about—such as the need to dose escalate imatinib in GIST patients with exon 9 mutations as compared with those with exon 11 mutations. This is a definite winner! 5. Criteria Catatonia: Do not forget to discuss the newest computed tomography or positron emission tomography criteria for determining response … especially if you plan to discuss an obscure malignancy that even oncologists rarely encounter (eg, esthesioneuroblastoma). Should you plan to discuss a common disease you can ensure ennui only if you will spend extra time discussing RECIST criteria. Now if you do this well, some audience members may begin fashioning their breakfast burritos into projectiles—each one aimed squarely at YOU. Be brave … soldier on! 6. Kaplan-Meier Killer: Make sure to discuss the arcane details of multiple negative phase II and III trials pertaining to the cancer under discussion. It is best to show several inconsequential and hard-to-read Kaplan-Meier plots. To make sure that you do a bad job, divide this portion of your presentation into two sections … one focused on adjuvant treatment; the second part should consist of a long boring soliloquy on the management of metastatic disease. Provide detailed information of little interest even to the most ardent fan of the disease you are discussing. This alone will almost certainly ensure that you will never, ever be asked to give Medicine Grand Rounds again. 7. Lymph Node Lobotomy: For the coup de grâce, be sure to include an exhaustive discussion of the latest surgical techniques, down to the precise number of lymph nodes required for an “adequate dissection.” To be fair, such details can be invaluable in specialized settings like a tumor board, where they send subspecialists into rapturous delight. But in the context of MGR—where the audience spans multiple disciplines—it will almost certainly induce a stultifying torpor. If dullness were an art, this would be its masterpiece—capable of lulling even the most caffeinated minds into a stupor. If you have carefully followed the above set of rules, at this point, some members of the audience should be banging their heads against the nearest hard surface. If you then hear a loud THUD … and you're still standing … you will know you have succeeded in giving the world's worst Medical Grand Rounds!   Final Thoughts I hope that these rules shed light on what makes for a truly dreadful oncology MGR presentation—which, by inverse reasoning, might just serve as a blueprint for an excellent one. At its best, an outstanding lecture defies expectations. One of the most memorable MGRs I have attended, for instance, was on prostaglandin function—not a subject typically associated with edge-of-your-seat suspense. Given by a biochemist and physician from another subspecialty, it could have easily devolved into a labyrinth of enzymatic pathways and chemical structures. Instead, the speaker took a different approach: rather than focusing on biochemical minutiae, he illustrated how prostaglandins influence nearly every major physiologic system—modulating inflammation, regulating cardiovascular function, protecting the gut, aiding reproduction, supporting renal function, and even influencing the nervous system—without a single slide depicting the prostaglandin structure. The result? A room full of clinicians—not biochemists—walked away with a far richer understanding of how prostaglandins affect their daily practice. What is even more remarkable is that the talk's clarity did not just inform—it sparked new collaborations that shaped years of NIH-funded research. Now that was an MGR masterpiece. At its core, effective scientific communication boils down to three deceptively simple principles: understanding your audience, focusing on relevance, and making complex information accessible.2 The best MGRs do not drown the audience in details, but rather illuminate why those details matter. A great lecture is not about showing how much you know, but about ensuring your audience leaves knowing something they didn't before. For those who prefer the structured wisdom of a written guide over the ramblings of a curmudgeon, an excellent review of these principles—complete with a handy checklist—is available.2 But fair warning: if you follow these principles, you may find yourself invited back to present another stellar MGRs. Perish the thought! Dr. Mikkael SekeresHello and welcome to JCO's Cancer Stories: The Art of Oncology, which features essays and personal reflections from authors exploring their experience in the oncology field. I'm your host, Mikkael Sekeres. I'm Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami.  What a pleasure it is today to be joined by Dr. David Johnson, clinical oncologist at the University of Texas Southwestern Medical School. In this episode, we will be discussing his Art of Oncology Practice article, "An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last."  Our guest's disclosures will be linked in the transcript.  David, welcome to our podcast and thanks so much for joining us. Dr. David JohnsonGreat to be here, Mikkael. Thanks for inviting me. Dr. Mikkael SekeresI was wondering if we could start with just- give us a sense about you. Can you tell us about yourself? Where are you from? And walk us through your career. Dr. David JohnsonSure. I grew up in a small rural community in Northwest Georgia about 30 miles south of Chattanooga, Tennessee, in the Appalachian Mountains. I met my wife in kindergarten. Dr. Mikkael SekeresOh my. Dr. David JohnsonThere are laws in Georgia. We didn't get married till the third grade. But we dated in high school and got married after college. And so we've literally been with one another my entire life, our entire lives. Dr. Mikkael SekeresMy word. Dr. David JohnsonI went to medical school in Georgia. I did my training in multiple sites, including my oncology training at Vanderbilt, where I completed my training. I spent the next 30 years there, where I had a wonderful career. Got an opportunity to be a Division Chief and a Deputy Director of, and the founder of, a cancer center there. And in 2010, I was recruited to UT Southwestern as the Chairman of Medicine. Not a position I had particularly aspired to, but I was interested in taking on that challenge, and it proved to be quite a challenge for me. I had to relearn internal medicine, and really all the subspecialties of medicine really became quite challenging to me. So my career has spanned sort of the entire spectrum, I suppose, as a clinical investigator, as an administrator, and now as a near end-of-my-career guy who writes ridiculous articles about grand rounds. Dr. Mikkael SekeresNot ridiculous at all. It was terrific. What was that like, having to retool? And this is a theme you cover a little bit in your essay, also, from something that's super specialized. I mean, you have had this storied career with the focus on lung cancer, and then having to expand not only to all of hematology oncology, but all of medicine. Dr. David JohnsonIt was a challenge, but it was also incredibly fun. My first few days in the chair's office, I met with a number of individuals, but perhaps the most important individuals I met with were the incoming chief residents who were, and are, brilliant men and women. And we made a pact. I promised to teach them as much as I could about oncology if they would teach me as much as they could about internal medicine. And so I spent that first year literally trying to relearn medicine. And I had great teachers. Several of those chiefs are now on the faculty here or elsewhere. And that continued on for the next several years. Every group of chief residents imparted their wisdom to me, and I gave them what little bit I could provide back to them in the oncology world. It was a lot of fun. And I have to say, I don't necessarily recommend everybody go into administration. It's not necessarily the most fun thing in the world to do. But the opportunity to deal one-on-one closely with really brilliant men and women like the chief residents was probably the highlight of my time as Chair of Medicine. Dr. Mikkael SekeresThat sounds incredible. I can imagine, just reflecting over the two decades that I've been in hematology oncology and thinking about the changes in how we diagnose and care for people over that time period, I can only imagine what the changes had been in internal medicine since I was last immersed in that, which would be my residency. Dr. David JohnsonWell, I trained in the 70s in internal medicine, and what transpired in the 70s was kind of ‘monkey see, monkey do'. We didn't really have a lot of understanding of pathophysiology except at the most basic level. Things have changed enormously, as you well know, certainly in the field of oncology and hematology, but in all the other fields as well. And so I came in with what I thought was a pretty good foundation of knowledge, and I realized it was completely worthless, what I had learned as an intern and resident. And when I say I had to relearn medicine, I mean, I had to relearn medicine. It was like being an intern. Actually, it was like being a medical student all over again. Dr. Mikkael SekeresOh, wow. Dr. David JohnsonSo it's quite challenging.  Dr. Mikkael SekeresWell, and it's just so interesting. You're so deliberate in your writing and thinking through something like grand rounds. It's not a surprise, David, that you were also deliberate in how you were going to approach relearning medicine. So I wonder if we could pivot to talking about grand rounds, because part of being a Chair of Medicine, of course, is having Department of Medicine grand rounds. And whether those are in a cancer center or a department of medicine, it's an honor to be invited to give a grand rounds talk. How do you think grand rounds have changed over the past few decades? Can you give an example of what grand rounds looked like in the 1990s compared to what they look like now? Dr. David JohnsonWell, I should all go back to the 70s and and talk about grand rounds in the 70s. And I referenced an article in my essay written by Dr. Ingelfinger, who many people remember Dr. Ingelfinger as the Ingelfinger Rule, which the New England Journal used to apply. You couldn't publish in the New England Journal if you had published or publicly presented your data prior to its presentation in the New England Journal. Anyway, Dr. Ingelfinger wrote an article which, as I say, I referenced in my essay, about the graying of grand rounds, when he talked about what grand rounds used to be like. It was a very almost sacred event where patients were presented, and then experts in the field would discuss the case and impart to the audience their wisdom and knowledge garnered over years of caring for patients with that particular problem, might- a disease like AML, or lung cancer, or adrenal insufficiency, and talk about it not just from a pathophysiologic standpoint, but from a clinician standpoint. How do these patients present? What do you do? How do you go about diagnosing and what can you do to take care of those kinds of patients? It was very patient-centric. And often times the patient, him or herself, was presented at the grand rounds. And then experts sitting in the front row would often query the speaker and put him or her under a lot of stress to answer very specific questions about the case or about the disease itself.  Over time, that evolved, and some would say devolved, but evolved into more specialized and nuanced presentations, generally without a patient present, or maybe even not even referred to, but very specifically about the molecular biology of disease, which is marvelous and wonderful to talk about, but not necessarily in a grand round setting where you've got cardiologists sitting next to endocrinologists, seated next to nephrologists, seated next to primary care physicians and, you know, an MS1 and an MS2 and et cetera. So it was very evident to me that what I had witnessed in my early years in medicine had really become more and more subspecialized. As a result, grand rounds, which used to be packed and standing room only, became echo chambers. It was like a C-SPAN presentation, you know, where local representative got up and gave a talk and the chambers were completely empty. And so we had to go to do things like force people to attend grand rounds like a Soviet Union-style rally or something, you know. You have to pay them to go. But it was really that observation that got me to thinking about it.  And by the way, I love oncology and I'm, I think there's so much exciting progress that's being made that I want the presentations to be exciting to everybody, not just to the oncologist or the hematologist, for example. And what I was witnessing was kind of a formula that, almost like a pancake formula, that everybody followed the same rules. You know, “This disease is the third most common cancer and it presents in this way and that way.” And it was very, very formulaic. It wasn't energizing and exciting as it had been when we were discussing individual patients. So, you know, it just is what it is. I mean, progress is progress and you can't stop it. And I'm not trying to make America great again, you know, by going back to the 70s, but I do think sometimes we overthink what medical grand rounds ought to be as compared to a presentation at ASH or ASCO where you're talking to subspecialists who understand the nuances and you don't have to explain the abbreviations, you know, that type of thing. Dr. Mikkael SekeresSo I wonder, you talk about the echo chamber of the grand rounds nowadays, right? It's not as well attended. It used to be a packed event, and it used to be almost a who's who of, of who's in the department. You'd see some very famous people who would attend every grand rounds and some up-and-comers, and it was a chance for the chief residents to shine as well. How do you think COVID and the use of Zoom has changed the personality and energy of grand rounds? Is it better because, frankly, more people attend—they just attend virtually. Last time I attended, I mean, I attend our Department of Medicine grand rounds weekly, and I'll often see 150, 200 people on the Zoom. Or is it worse because the interaction's limited? Dr. David JohnsonYeah, I don't want to be one of those old curmudgeons that says, you know, the way it used to be is always better. But there's no question that the convenience of Zoom or similar media, virtual events, is remarkable. I do like being able to sit in my office where I am right now and watch a conference across campus that I don't have to walk 30 minutes to get to. I like that, although I need the exercise. But at the same time, I think one of the most important aspects of coming together is lost with virtual meetings, and that's the casual conversation that takes place. I mentioned in my essay an example of the grand rounds that I attended given by someone in a different specialty who was both a physician and a PhD in biochemistry, and he was talking about prostaglandin metabolism. And talk about a yawner of a title; you almost have to prop your eyelids open with toothpicks. But it turned out to be one of the most fascinating, engaging conversations I've ever encountered. And moreover, it completely opened my eyes to an area of research that I had not been exposed to at all. And it became immediately obvious to me that it was relevant to the area of my interest, which was lung cancer. This individual happened to be just studying colon cancer. He's not an oncologist, but he was studying colon cancer. But it was really interesting what he was talking about. And he made it very relevant to every subspecialist and generalist in the audience because he talked about how prostaglandin has made a difference in various aspects of human physiology.  The other grand rounds which always sticks in my mind was presented by a long standing program director at my former institution of Vanderbilt. He's passed away many years ago, but he gave a fascinating grand rounds where he presented the case of a homeless person. I can't remember the title of his grand rounds exactly, but I think it was “Care of the Homeless” or something like that. So again, not something that necessarily had people rushing to the audience. What he did is he presented this case as a mysterious case, you know, “what is it?” And he slowly built up the presentation of this individual who repeatedly came to the emergency department for various and sundry complaints. And to make a long story short, he presented a case that turned out to be lead poisoning. Everybody was on the edge of their seat trying to figure out what it was. And he was challenging members of the audience and senior members of the audience, including the Cair, and saying, “What do you think?” And it turned out that the patient became intoxicated not by eating paint chips or drinking lead infused liquids. He was burning car batteries to stay alive and inhaling lead fumes, which itself was fascinating, you know, so it was a fabulous grand rounds. And I mean, everybody learned something about the disease that they might otherwise have ignored, you know, if it'd been a title “Lead Poisoning”, I'm not sure a lot of people would have shown up. Dr. Mikkael Sekeres That story, David, reminds me of Tracy Kidder, who's a master of the nonfiction narrative, will choose a subject and kind of just go into great depth about it, and that subject could be a person. And he wrote a book called Rough Sleepers about Jim O'Connell - and Jim O'Connell was one of my attendings when I did my residency at Mass General - and about his life and what he learned about the homeless. And it's this same kind of engaging, “Wow, I never thought about that.” And it takes you in a different direction.  And you know, in your essay, you make a really interesting comment. You reflect that subspecialists, once eager to share their insight with the wider medical community, increasingly withdraw to their own specialty specific conferences, further fragmenting the exchange of knowledge across disciplines. How do you think this affects their ability to gain new insights into their research when they hear from a broader audience and get questions that they usually don't face, as opposed to being sucked into the groupthink of other subspecialists who are similarly isolated? Dr. David Johnson That's one of the reasons I chose to illustrate that prostaglandin presentation, because again, that was not something that I specifically knew much about. And as I said, I went to the grand rounds more out of a sense of obligation than a sense of engagement. Moreover, our Chair at that institution forced us to go, so I was there, not by choice, but I'm so glad I was, because like you say, I got insight into an area that I had not really thought about and that cross pollination and fertilization is really a critical aspect. I think that you can gain at a broad conference like Medical Grand Rounds as opposed to a niche conference where you're talking about APL. You know, everybody's an APL expert, but they never thought about diabetes and how that might impact on their research. So it's not like there's an ‘aha' moment at every Grand Rounds, but I do think that those kinds of broad based audiences can sometimes bring a different perspective that even the speaker, him or herself had not thought of. Dr. Mikkael SekeresI think that's a great place to end and to thank David Johnson, who's a clinical oncologist at the University of Texas Southwestern Medical School and just penned the essay in JCO Art of Oncology Practice entitled "An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last."  Until next time, thank you for listening to JCO's Cancer Stories: The Art of Oncology. Don't forget to give us a rating or review, and be sure to subscribe so you never miss an episode. You can find all of ASCO's shows at asco.org/podcasts.  David, once again, I want to thank you for joining me today. Dr. David JohnsonThank you very much for having me. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.    Show notes: Like, share and subscribe so you never miss an episode and leave a rating or review.  Guest Bio: Dr David Johnson is a clinical oncologist at the University of Texas Southwestern Medical School.

Event ObjectivesRecall and summarize the role of allergy testing and challenge in diagnosis of penicillin allergy.Describe the detrimental clinical consequences of being labeled penicillin allergic.Apply their knowledge to de-label penicillin allergy in their practice.Claim CME Credit here!

Dr. Molly Fuentes is medical director at the inpatient rehabilitation unit at the Seattle Children's Hospital. Dr. Fuentes is an assistant professor of rehabilitation medicine at the University of Medicine. She also is a pediatric physiatrist. She completed her undergraduate degree at Stanford University and is a graduate of the School of Medicine at the University of Michigan. She completed her residency at the University of Washington and later completed a pediatric fellowship at the Seattle Children's Hospital. She then completed a research fellowship in pediatric injury at the Harborview Injury Prevention and Research Center at the University of Washington. She is the medical director at the inpatient rehabilitation unit at the Seattle Children's Hospital.   Part 1 Dr. Fuentes described her life experiences that influenced her choice of a career in the area of pediatric disability. In this presentation, she wanted to: review the injury epidemiology literature for American Indian and Alaska Native children and teens, identify some historical traumas that impact native people, recognize the utility of the injury-equity framework, the international classification of functioning disability and health model, conceptualize rehabilitative care, and describe some barriers to rehabilitation care. A health disparity is just that difference in health status between population groups. A health disparity becomes an inequity when that disparity is due to systematic differences in social, economic, environmental, or health care resources. There is a health care inequity when there is a difference in access to health care utilization or receipt of health care services. Looking specifically at disability and functional difference among American Indian and Alaska Native children, there really is not that much published literature on the prevalence of disability in this population. Dr. Fuentes concluded Part 1 by discussing historical relationships between Native American tribes and the federal government, which have had a significant deleterious impact on individual and community health status of these individuals. For example, boarding schools or residence schools represent another kind of push in the direction of forced assimilation where traditional practices were punished.

Event Objectives:Have assumptions related to sexual harm challenged in addition to gaining new insights on the subject.Claim CME Credit Here!

Event Objectives:Explore the history and evolution of terms related to non-accidental head trauma in infants.Describe the clinical characteristics of abusive head trauma (AHT).Discuss strategies to identify infants at risk for AHT.Claim CME Credit Here!

The academia-industry interface is more important than ever for sustaining biomedical innovation's forward momentum, even as the Trump administration injects turbulence into academic funding for universities. On a special edition of the BioCentury This Week podcast, BioCentury's Simone Fishburn and Karen Tkach Tuzman preview Grand Rounds, BioCentury's second annual R&D conference, along with special guests.Spots are filling up for the Grand Rounds U.S. Presenting Company Class of 2025. Find out how to apply here.View full story: https://www.biocentury.com/article/655696#biotech #biopharma #pharma #lifescience #academia #chicago #asco00:00 - Introduction01:42 - Key Themes and Featured Sessions07:37 - Chicago's Role in Biotech Innovation15:06 - McKinsey's Insights25:18 - Upcoming Events and Networking OpportunitiesTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

More and more people are, “doing their own research.”  Self-identified experts and influencers on podcasts (podcasts!) and social media endorse treatments that are potentially harmful and have little to no evidence of benefit, or have only been studied in animals.  An increasing number of federal leaders have a track record of endorsing such products. We and our guests have noticed that in our clinical practices, patients and caregivers seem to be asking for such treatments more frequently.  Ivermectin to treat cancer.  Stem cell treatments. Chelation therapy.  Daneila Lamas wrote about this issue in the New York Times this week -after we recorded - in her story, a family requested an herbal infusion for their dying mother via feeding tube. Our guests today, Adam Marks, Laura Taylor, & Jill Schneiderhan, have coined a term for such therapies, for Potentially Unsafe Low-evidence Treatments, or PULET. Rhymes with mullet (On the podcast we debate using the French pronunciation, though it sounds the same as the French word for chicken).  We discuss an article they wrote about PULET for the American Journal of Hospice and Palliative Medicine, including: What makes a PULET a PULET?  Key ingredients are both potentially unsafe and low evidence.  If it's low evidence but not unsafe, not generally an issue.  Think vitamins. If it's potentially unsafe, but has robust evidence, well that's most of the treatments we offer seriously ill patients!  Think chemo. What counts as potentially unsafe? They include what might be obvious, e.g. health risks, and less obvious, e.g. financial toxicity. What counts as low-evidence?  Animal studies? Theoretical only? Does PULET account for avoiding known effective treatments? Do elements of care that are often administered to seriously ill patients count? Yes. Think chemotherapy to imminently dying patients, or CPR. How does integrative medicine fit in with this?  Jill Schneiderhan, a family medicine and integrative medicine doc, helps us think through this. How ought clinicians respond?  Hint: If you're arguing over the scientific merits of a research study, you're probably not doing it right.  Instead, think VitalTalk, REMAP, and uncover and align with the emotion behind the request. Does the approach shift when it's a caregiver requesting PULET for an older relative who lost capacity? How about parents advocating for a child? For more, Laura suggests a book titled, How to Talk to a Science Denier.   And I am particularly happy that the idea for this podcast arose from my visit to Michigan to give Grand Rounds, and the conversations I had with Adam and Laura during the visit.  We love it when listeners engage with us to suggest topics that practicing clinicians find challenging. And I get to sing Bon Jovi's Bad Medicine, which is such a fun song! -Alex Smith  

Event Objectives:Review the Historical Progression of Interventional Cardiology in Pediatric and Congenital Heart Disease.Highlight Cutting-Edge Catheter-Based Therapies for Pediatric and Congenital Heart Conditions.Understand Contemporary Catheter-Based Arrhythmia Management Options in Pediatric and Congenital Heart Disease.Claim CME Credit Here!

Join Elevated GP: www.theelevatedgp.com Free Class II Masterclass - Click Here to Join Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Stanley Liu (“Leo”) received his undergraduate education from Stanford University. He completed DDS and MD degrees, with General Surgery internship and Oral & Maxillofacial Surgery residency, from the University of California – San Francisco (UCSF). After Sleep Surgery Fellowship at Stanford Medical School in 2014, he was appointed faculty in the Department of Otolaryngology until 2023. He rose to the rank of Associate Professor, and Director of the Sleep Surgery Fellowship. Concurrently, he was a Preceptor of the Oculoplastic Surgery Fellowship and held a courtesy appointment to the Division of Plastic & Reconstructive Surgery.  In February 2024, he joined Nova Southeastern University as the Chair of the Department of Oral & Maxillofacial Surgery, and Assistant Dean of Hospital Affairs. Dr. Liu is a Fellow of the American College of Surgeons (FACS), and the American College of Oral & Maxillofacial Surgeons. He has been a Howard Hughes Medical Institute (HHMI) Scholar, and Stanford Biodesign Faculty Fellow. He serves on the board or executive positions of the California Sleep Society (CSS), American Academy of Physiologic Medicine & Dentistry (AAPMD), and the World Dentofacial Sleep Society (WDSS). He is a consultant member in the sleep section of the American Academy of Otolaryngology – Head & Neck Surgery (AAO-HNS). Dr. Liu's clinical and research focus are on surgical approaches to obstructive sleep apnea. With his surgical mentor and sleep surgery pioneer, Dr. Robert Riley, the Stanford Sleep Surgery approach was updated to integrate drug-induced sleep endoscopy (DISE), nasal surgery including maxillary expansion (DOME), pharyngeal surgery (UPPP), hypoglossal nerve stimulation (HGNS), and maxillomandibular advancement (MMA).  His bibliography lists over 90 journal articles and 20 book chapters. He has been a Grand Rounds speaker at academic programs including UCSF, Northwestern, OHSU, LSU, and Stanford. He has been a Keynote Speaker for preeminent sleep and surgery meetings, including the 33rd SLEEP in 2019, and World Sleep in 2023.

Event Objectives:Discuss how trauma care starts well before the trauma bay and lasts long after.Explain additional resources beyond the surgical trauma team that lead to best outcomes in trauma care.Consider how addressing mental health and legal challenges can help in trauma recovery.Claim CME Credit Here!

The rapid evolution of digital health is transforming emergency care, but how do we design and implement technologies that truly meet patient needs? This session will explore the landscape of digital health tools and unpack how user-centered design ensures their effectiveness. Using a phased approach to development, Dr. Lauren Chernick from Columbia emergency medicine will discuss key strategies for integrating technology into engaging mobile health interventions. She will also share insights from three real-world sexual health interventions designed for adolescents in the ED—highlighting both successes and challenges. Join us for a discussion on digital health in emergency medicine and its potential to enhance patient care. CONTACTS X - @AlwaysOnEM; @VenkBellamkonda YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch Email - AlwaysOnEM@gmail.com  

Event Objectives:List the topical medications approved by the FDA for use in pediatric dermatologic diseases in the past five years.Describe the general risks and benefits of recently-approved systemic medications approved for use in pediatric dermatologic diseases.Claim CME Credit Here!

  Join Elevated GP: www.theelevatedgp.com Free Class II Masterclass - Click Here to Join Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Stanley Liu (“Leo”) received his undergraduate education from Stanford University. He completed DDS and MD degrees, with General Surgery internship and Oral & Maxillofacial Surgery residency, from the University of California – San Francisco (UCSF). After Sleep Surgery Fellowship at Stanford Medical School in 2014, he was appointed faculty in the Department of Otolaryngology until 2023. He rose to the rank of Associate Professor, and Director of the Sleep Surgery Fellowship. Concurrently, he was a Preceptor of the Oculoplastic Surgery Fellowship and held a courtesy appointment to the Division of Plastic & Reconstructive Surgery.  In February 2024, he joined Nova Southeastern University as the Chair of the Department of Oral & Maxillofacial Surgery, and Assistant Dean of Hospital Affairs. Dr. Liu is a Fellow of the American College of Surgeons (FACS), and the American College of Oral & Maxillofacial Surgeons. He has been a Howard Hughes Medical Institute (HHMI) Scholar, and Stanford Biodesign Faculty Fellow. He serves on the board or executive positions of the California Sleep Society (CSS), American Academy of Physiologic Medicine & Dentistry (AAPMD), and the World Dentofacial Sleep Society (WDSS). He is a consultant member in the sleep section of the American Academy of Otolaryngology – Head & Neck Surgery (AAO-HNS). Dr. Liu's clinical and research focus are on surgical approaches to obstructive sleep apnea. With his surgical mentor and sleep surgery pioneer, Dr. Robert Riley, the Stanford Sleep Surgery approach was updated to integrate drug-induced sleep endoscopy (DISE), nasal surgery including maxillary expansion (DOME), pharyngeal surgery (UPPP), hypoglossal nerve stimulation (HGNS), and maxillomandibular advancement (MMA).  His bibliography lists over 90 journal articles and 20 book chapters. He has been a Grand Rounds speaker at academic programs including UCSF, Northwestern, OHSU, LSU, and Stanford. He has been a Keynote Speaker for preeminent sleep and surgery meetings, including the 33rd SLEEP in 2019, and World Sleep in 2023.

Event Objectives:Provide pediatric healthcare professionals with the knowledge strategies and actionable recommendations on addressing trauma mental health challenges and gun violence within the pediatric population.Claim CME Credit Here!

The Role of Viruses in Asthma Development and Severity

Life in the intensive care unit can be overwhelming. Patients may be intubated, disoriented, and scared. Families may be looking for answers from any provider who enters the room. For SLPs, the environment is noisy and ever-changing, and the stakes couldn't be higher.On the podcast, SLPs take us behind the scenes to share stories from the ICU. In a wide-ranging discussion, they tackle the significant role SLPs play in managing dysphagia and communication there.From the recent history that led SLPs to begin working in the ICU, to the SLP's biggest ally in that environment, to what can happen to patients when they're discharged, guests Marty Brodsky (Cleveland Clinic; Johns Hopkins) and Marta Kazandjian (Stony Brook Southampton Hospital; Stony Brook School of Health Professions) share their insights and expertise.Learn More:ASHA Health Care Summit 2025: Grand Rounds in the ICUASHA Voices: The Difference Patient Counseling MakesWheeling AAC Support for Aphasia Into the ICUASHA Practice Portal: Tracheostomy and Ventilator DependenceTranscriptSupport for this episode of ASHA Voices comes from Medbridge.

European venture firm Sofinnova Partners is expanding the reach of its Biovelocita accelerator beyond Italy to stretch across the greater continent. On the latest BioCentury This Week podcast, BioCentury's editors discuss how Biovelocita became the largest life sciences accelerator in Europe. The editors also discuss Novo Nordisk's latest addition to its obesity pipeline via a deal in China, and how the partnership reflects the state of cross-border dealmaking more broadly. And Washington Editor Steve Usdin assesses President Trump's threat to impose 25% tariffs on pharmaceutical imports and provides an update on how FDA's staff is navigating the policies of the new administration. Finally, Editor in Chief Simone Fishburn discusses BioCentury's upcoming Grand Rounds meetings.View full story: https://www.biocentury.com/article/65543800:00 - Introduction02:25 - Sofinnova's Pan-European Accelerator08:27 - China Biotechs14:59 - Trump TariffsTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Event Objectives:Discuss the research on the mental health of transgender and gender diverse youth.Analyze the legislative efforts to limit access to gender affirming care for youth.Review the perspectives of parents and caregivers of transgender youth.Claim CME Credit Here!

Event Objectives:Define pediatric intestinal failure and evaluate its prognosis.Create a successful nutritional medical and surgical plan for children with pediatric intestinal failure.Identify remaining challenges in the treatment of pediatric intestinal failure.Claim CME Credit Here!

In this Grand Rounds chapter, Dr. Alex Ginsburg, board certified in both emergency medicine and palliative care, and physician leader practicing in both specialties at Mayo Clinic in Rochester, Minnesota discusses a pragmatic way to incorporate palliative care into a busy and complicated emergency medicine practice. Beginning with why this is important and highlighting the challenges and barriers to making this happen, Dr. Ginsburg then proceeds to talk through approaches that are patient-centric while simultaneously feasible for a busy emergency physician. He will call out specific patients and scenarios that would benefit from consulting palliative care if possible and then cover optimal practices in how to clarify the goals of care of your patient. Tune in for this incredibly important Mayo Clinic Emergency Medicine Grand Rounds! CONTACTS X - @AlwaysOnEM; @VenkBellamkonda YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch Email - AlwaysOnEM@gmail.com

Event Objectives:List common indications for fetal MRI.Discuss improvements in the last 2 decades of fetal imaging.Known when patients might be a candidate for prenatal intervention.Claim CME Credit Here!

Event Objectives:Familiarize yourself with the 2017 updated definitions suggested work up and treatment of pediatric hypertension.Understand the acute and long term complications of pediatric hypertension.Obtain a basic understanding of indications and interpretation of ambulatory blood pressure monitoring.Claim CME Credit Here!

Event Objectives:Discuss the various components that comprise the field of wilderness medicine.Review the expectations for children of various ages when in the wilderness.Identify preventive care strategies for pediatric patients with regard to wilderness injuries and exposures.Claim CME Credit Here!

February 21, 2025 Scott and Mark discuss questions from the PRS Network Community and the Thriving Urology Practice Facebook group.Does anyone bill out a removal of testicular appendix separately from the hydrocelectomy? I have a new physician that is submitting 55040 and 54512.After presenting Grand Rounds on billing/coding the question arose that our billing department is billing g G2211 with a modifier 25 and getting paid. That goes against what I learned and what I presented. Leveraging Provider PortalsFree Kidney Stone Coding CalculatorDownload NowPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.https://www.prsnetwork.com/joinuptp Click Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

Event Objectives:Explain how the Children's Hospital Association advocates with policymakers to ensure children's access to healthcare.Describe the current political climate in Washington, D.C.Claim CME Credit Here!

Legendary emergency medicine educator, Dr. Brit Long, gave grand rounds in Rochester in a highly interactive experience covering high risk, yet low frequency conditions that we need to watch for on shift. He uses an engaging style filled with cases to drill home key points related to these conditions. Enjoy this Valentine's Day chapter of Always on EM-Grand Rounds for a fun and engaging reminder of what our specialty is all about!   CONTACTS X - @AlwaysOnEM; @VenkBellamkonda; @Long_Brit YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch Email - AlwaysOnEM@gmail.com

Event Objectives:Understand basic diagnostic tests for congenital CMV hearing loss genes and utility of CT vs. MRI temporal bone imaging.Use the HL algorithm to develop an effective diagnostic strategy for unilateral/bilateral sensorineural and mixed hearing loss.Find causes that are potentially treatable dangerous if missed or affect prognosis.Understand role of emerging gene therapy.Claim CME Credit Here!

Event Objectives:Defining GH in 2025GH and Newborn HealthOverview of a GH initiative in republic of MauritiusClaim CME Credit Here!

Step into the world of Nutrition Grand Rounds with this exclusive sneak peek! In this episode, I'm sharing handpicked clips from our latest presentation on bone health, featuring two dietitians, Grace Rivers and Stephanie Turkel. With over 30 years of experience, they're sharing actionable tips and eye-opening insights to help you guide your patients toward stronger, healthier bones.If you think you're already covering all the bases with your patients' bone health, think again. From the surprising truth about salads to decoding DEXA scans, this episode has something for everyone!Here's what you'll learn:Why 7 out of 10 women over 50 are at risk for low bone mass—and what you can do about it.The critical nutrients your patients are likely missing (hint: it's not just calcium and vitamin D).How to help patients build meals that are actually filling and nutrient-packed.This is just a small taste of what Nutrition Grand Rounds has to offer. We're building a community of passionate healthcare professionals who want to stay on the cutting edge of nutrition science and bring that knowledge into the exam room. Our next live session is on February 12 at noon EST, featuring Dr. Basma Faris—an OBGYN, Registered Dietitian, and certified culinary medicine specialist. She'll be breaking down the latest nutrition guidelines for managing PCOS. If you can't make it live, the recordings are available. Join now at nutritiongrandrounds.com!  This is your chance to learn from the best, ask questions, and walk away with actionable insights that can transform your patients' lives.  Connect with Grace and Stephanie:Practicaldietitians.comAny Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for the Nutrition Wrap-Up Newsletter - Nutrition hot-topics and professional growth strategies delivered to your inbox each week. Support the show!If you love the show and want to help me make it even better, buy me a coffee to help me keep going! ☕️Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer.

Event Objectives:Discuss basic knowledge regarding children's rights under federal and state law to necessary services.Discuss legal entitlements including: Medicaid Americans with Disabilities Act and the Individuals with Disabilities Education Act.Discuss common barriers to services faced by children and families and advocacy strategies to remedy these barriers.Claim CME Credit Here!

Event Objectives:Understand the problem with neurulation in the development of open neural tube defects and the “second hit hypothesis."Understand the results of the MOMS Trial and the implications for prenatal repair myelomeningocele.Understand the limitations of our current approach to prenatal myelomeningocele repair and technical advances which have the potential to improve outcomes in the future.Claim CME Credit Here!

Drs. Kat Talcott, Akshay Thomas, and Sarwar Zahid join the podcast for a journal club discussion covering three recent articles in major ophthalmology journals.Pneumatic Retinopexy IRIS Registry (https://www.ophthalmologyretina.org/article/S2468-6530(24)00526-8/fulltext)Macular Perfusion in Stable PDR (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2826881)Female Speaker Introductions (https://www.ajo.com/article/S0002-9394(24)00522-1/fulltext)Relevant Financial Disclosures: Dr. Sridhar has consulted for Alcon.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

In this return appearance on NEJM AI Grand Rounds, Dr. Zak Kohane joins hosts Raj Manrai and Andy Beam to discuss the evolving landscape of AI in medicine. As the first repeat guest on the show, Dr. Kohane shares insights on health care system challenges, the Human Values Project, and his perspectives on the most significant AI developments of 2024. The conversation explores everything from the practical applications of AI in health care to philosophical discussions about machine psychology and the future of doctor-patient relationships. Transcript. 

Dr. Lekshmi Kumar, Associate Professor of Emergency Medicine at Emory University / Grady Hospital system in Atlanta, Georgia and the EMS director or the city of Atlanta presents grand rounds to kick off the 2025 calendar year! She talks about their collaborative work to create a prehospital blood transfusion program to uplift the trauma care in their region. Tune in to learn about the method for handling the change, the specifics for implementation and to learn the difference that this is making for their patients.  CONTACTS X - @AlwaysOnEM; @VenkBellamkonda YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch Email - AlwaysOnEM@gmail.com

In this final episode of the third season of the Always on EM podcast, we share a grand rounds recording of Dr. Adiba Matin, former resident at Mayo Clinic giving her senior capstone presentation on climate change and emergency medicine. In this visionary presentation, she projects physiologic consequences of the climate change on human health, as well as discusses adaptations for clinical practices, highlights how environmental change might impact social determinants of health, and touches on ways to become advocates for climate protective practices. Close out the new year with the hottest presentation in the grand rounds offerings so far!

Adrenal Insufficiency for the Pediatric Anesthesiologist with Melinda Pierce, MD, MCR

In this episode of The Brave Enough Show, Dr. Sasha Shillcutt and Dr. Diana Pallin discuss:    How to make good choices when you are stressed out  Picking through bad advice and finding experts  Giving yourself grace to make 10% changes  Making your own nutrition a foundation of your health    “If I do not have good nutrition, I cannot make good decisions, I cannot take care of myself, and therefore, I cannot take care of anyone else who needs me.” - Dr. Diana Pallin    Dr Diana Pallin is Board Certified in Internal Medicine and Obesity Medicine and has been practicing Obesity medicine since 2013. She is a TEDx speaker, member of the Obesity Medicine Association and founder of New Start Medical, a metabolic practice that offers comprehensive weight management programs which follow the Obesity Medicine Association guidelines.   She is passionate about offering her patients the tools needed to be successful in their weight management journey, in a medically supervised setting. Management of cardio-metabolic conditions modified by lifestyle changes is an important part of her practice. Becoming an obesity medicine specialist has allowed her to help patients improve their health and quality of life, lose weight safely and prevent developing chronic, metabolic conditions associated with carrying extra weight.  She was born in Romania, graduated from Iuliu Hatieganu University of Medicine and Pharmacy in Cluj Napoca. Completed her residency at New Hanover Regional Medical Center in Wilmington, NC where she was chief resident and was responsible for creating the educational curriculum for Grand Rounds and morning reports.   On her time off, she enjoys spending time with her family, traveling to new places and enjoys spending time in nature.     Website:  www.newstartmedical.com    Social:  LinkedIn Facebook  New Start Facebook      Episode Links:  BE24 Conference Brave Boundaries RISE Mastermind   Follow Brave Enough:   WEBSITE | INSTAGRAM | FACEBOOK | TWITTER | LINKEDIN Join The Table, Brave Enough's community. The ONLY professional membership group that meets both the professional and personal needs of high-achieving women.

Burnout is caused by many factors but can cause physical manifestations such as severe fatigue, headaches and lack of sleep. Tiffany Cagwin is a holistic life coach who works with many healthcare professionals to help them recover physically.   She talks today about getting the body back into the proper circadian cycle by incorporating a couple very simple tasks into your daily routine. You can learn more about her at www.TiffanyCagwin.com.       

A final thank you to all the loyal listeners as we end the Financial Residency Podcast Series. Please visit our website, www.financialresidency.com when you need to find a trusted resource for physician mortgages.

Dr. Cory Fawcett literally wrote the book on "Managing a Financial Crisis" as part of his Doctor's Guide series. He joins us today to talk about the steps a physician can take to navigate the crisis by methodically evaluating resources and making a plan to move forward, deal with the emotional fallout, prevent loss of relationships from the event and hopefully come out in a better place on the other side. You can learn more about Dr. Fawcett, read his blog, take a course or obtain coaching at www.FinancialSuccessMD.com.

Dr. Stephanie Tarlow is a type 1 and an endocrinologist.  JUICE CRUISE 2025 Eat Hungryroot Screen It Like You Mean It Eversense CGM Learn about the Medtronic Champions This BetterHelp link saves 10% on your first month of therapy Try delicious AG1 - Drink AG1.com/Juicebox I Have Vision Use code JUICEBOX to save 30% at Cozy Earth  Get Gvoke HypoPen CONTOUR NextGen smart meter and CONTOUR DIABETES app Learn about the Dexcom G6 and G7 CGM Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Learn about Touched By Type 1 Take the T1DExchange survey *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  How to listen, disclaimer and more Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find the show and consider leaving a rating and review on Apple Podcasts. Thank you! The Juicebox Podcast is not a charitable organization.